FDA targets illegal pharma websites
The FDA has issued 22 Warning Letters to website operators as part of its International Internet Week of Action, which aims to curb illegal actions involving medical products. More...
Medicines top consumers' counterfeit concern list
Five per cent of consumers across five European countries suspect they may have received a counterfeit prescription and 1% believe that they definitely have, according to research conducted by ICM
Research
on behalf of patient safety communications company Aegate (UK). More...
EMEA reaffirms safety of pandemic vaccines
After further reviewing data on the H1N1 pandemic vaccines approved in Europe, the EMEA has reaffirmed their balance of benefits and risks in the context of the current H1N1 influenza pandemic. Additionally, the World Health Organization (WHO) has issued an update on the H1N1 situation in Europe. More...
Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...
SOCMA updates advocacy against IST provisions
The US Society for Chemical Manufacturers and Affiliates (SOCMA) has provided an update of its efforts regarding the recently passed US Chemical and Water Security Act of 2009 (HR 2868), which includes inherently safer technology (IST) requirements that SOCMA opposes. More...
Largest ever study of an antimalarial drug launched
An agreement between sanofi-aventis and the Medicines for Malaria Venture (MMV) has lead to the initiation of the largest safety and efficacy study of an antimalarial drug. More...
Are you following us?
Pharmaceutical Technology Europe is on Twitter. More...
| Product Profile |
| Alfa Laval |
|
Two new biopharm pumps
Alfa Laval has added two new biopharm pumps to its offering and can now meet a wider selection of customer needs at differentiated prices.
 Read more... |
|
|
| On Demand Webcast |
| Just Systems |
Complex Documents in the Pharmaceutical Industry Made Easy
Documents are created just about everywhere in the pharmaceutical industry. To manage interrelated documents, collaboratively created and updated, versioned and published to different targets can often turn into a nightmare. With XML authoring, recurrent tasks such as applying repetitive changes to similar documents or assuring quality for cross-referencing, can finally be automated.
 Read more... |
|
|
|
